Search research articles
Contact Us
Filters
Showing results (521-530 of 585) with videos related to
Page
of 59
Sort By:
Journal of Clinical Microbiology
|
June 1, 1990
Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins
S R Coates, A J Harris, D L Parkes, et al.
Cancer Research
|
May 19, 2006
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
Yan Zhao, Huw D Thomas, Michael A Batey, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2008
8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
Marine Desage-El Murr, Celine Cano, Bernard T Golding, et al.
American Journal of Medical Genetics. Part A
|
June 17, 2009
Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion
Eilis A Boudreau, Kyle P Johnson, Angela R Jackman, et al.
Human Genetics
|
June 4, 2014
Opposite effects on facial morphology due to gene dosage sensitivity
Peter Hammond, Shane McKee, Michael Suttie, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 14, 2013
An enzymatic route to selenazolines
Jesko Koehnke, Falk Morawitz, Andrew F Bent, et al.
Cancer Research
|
August 17, 2006
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe, Nicholas C Turner, Christopher J Lord, et al.
Nucleic Acids Research
|
December 18, 2023
Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells
Eeson Rajendra, Diego Grande, Bethany Mason, et al.
Obesity Research & Clinical Practice
|
July 10, 2024
Investigation of setmelanotide, an MC4R agonist, for obesity in individuals with Smith-Magenis syndrome
Julia Lazareva, Stephanie R Sisley, Sheila M Brady, et al.
Cancer Research
|
April 23, 2009
Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin
Trevor Hay, James R Matthews, Lucie Pietzka, et al.
Page
of 59
Search research articles
Search
Showing results (521-530 of 585) with videos related to
Sort By:
Page
of 59
Journal of Clinical Microbiology
|
June 1, 1990
Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins
S R Coates, A J Harris, D L Parkes, et al.
Cancer Research
|
May 19, 2006
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
Yan Zhao, Huw D Thomas, Michael A Batey, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2008
8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
Marine Desage-El Murr, Celine Cano, Bernard T Golding, et al.
American Journal of Medical Genetics. Part A
|
June 17, 2009
Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion
Eilis A Boudreau, Kyle P Johnson, Angela R Jackman, et al.
Human Genetics
|
June 4, 2014
Opposite effects on facial morphology due to gene dosage sensitivity
Peter Hammond, Shane McKee, Michael Suttie, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 14, 2013
An enzymatic route to selenazolines
Jesko Koehnke, Falk Morawitz, Andrew F Bent, et al.
Cancer Research
|
August 17, 2006
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe, Nicholas C Turner, Christopher J Lord, et al.
Nucleic Acids Research
|
December 18, 2023
Quantitative, titratable and high-throughput reporter assays to measure DNA double strand break repair activity in cells
Eeson Rajendra, Diego Grande, Bethany Mason, et al.
Obesity Research & Clinical Practice
|
July 10, 2024
Investigation of setmelanotide, an MC4R agonist, for obesity in individuals with Smith-Magenis syndrome
Julia Lazareva, Stephanie R Sisley, Sheila M Brady, et al.
Cancer Research
|
April 23, 2009
Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin
Trevor Hay, James R Matthews, Lucie Pietzka, et al.
Page
of 59